These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6795910)

  • 1. Inverse correlation between HDL apoproteins (A-I, A-II) and immunoglobulin (IgG).
    Koskenvuo M
    Am Heart J; 1981 Nov; 102(5):946-7. PubMed ID: 6795910
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The measurement of apolipoprotein A-I and A-II levels of human plasma high density lipoprotein (HDL) by single radial immunodiffusion (SRID) method].
    Miyahara T; Murai A; Kameyama M
    Nihon Ronen Igakkai Zasshi; 1982 Nov; 19(6):583-7. PubMed ID: 6820093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance.
    Scanu AM; Edelstein C; Gordon JI
    Clin Physiol Biochem; 1984; 2(2-3):111-22. PubMed ID: 6435927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunonephelometric measurement of apolipoproteins A-I and A-II by consecutive addition of the two antisera to a single specimen.
    Kuusi T; Palosuo T; Ehnholm C
    Clin Chem; 1984 Jul; 30(7):1265-6. PubMed ID: 6428781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-II can incorporate into plasma very low density lipoproteins.
    Mao SJ; Kluge K; Squillace SJ
    FEBS Lett; 1981 Sep; 132(2):289-92. PubMed ID: 6795063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II.
    Edelstein C; Halari M; Scanu AM
    J Biol Chem; 1982 Jun; 257(12):7189-95. PubMed ID: 6806266
    [No Abstract]   [Full Text] [Related]  

  • 11. Competitive enzyme immunoassay for apolipoprotein A-II.
    Dufaux B; Ilsemann K; Assmann G
    J Clin Chem Clin Biochem; 1983 Jan; 21(1):39-43. PubMed ID: 6406642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein metabolism in a patient with abetalipoproteninemia.
    Illingworth DR; Connor WE; Alaupovic P
    Ann Nutr Metab; 1981; 25(1):1-10. PubMed ID: 6789759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidylcholines between apolipoprotein-phospholipid recombinants.
    Massey JB; Gotto AM; Pownall HJ
    Biochemistry; 1982 Jul; 21(15):3630-6. PubMed ID: 6810929
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics.
    Biesbroeck RC; Albers JJ; Wahl PW; Weinberg CR; Bassett ML; Bierman EL
    Diabetes; 1982 Feb; 31(2):126-31. PubMed ID: 6818072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolation of apolipoproteins A-I, A-II and E and their estimation by rocket immunoelectrophoresis in blood plasma of dis-alpha-lipoproteinemic patients].
    Klimov AN; Usatenko MS; Denisenko AD; Kozhevnikova KA; Oleĩnik IA
    Biokhimiia; 1981 Apr; 46(4):590-602. PubMed ID: 6793091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization of unesterified cholesterol in high density lipoproteins probed by filipin.
    Blau L; Bittman R; Lagocki P; Byrne R; Scanu AM
    Biochim Biophys Acta; 1982 Sep; 712(3):437-43. PubMed ID: 6812643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apoproteins (structural characteristics and clinical significance)].
    Vergani C
    Ric Clin Lab; 1981; 11 Suppl 2():9-15. PubMed ID: 6798676
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA; Johnson O; Ericsson M; Tollin C
    Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein-specific populations in high density lipoproteins of human cord blood.
    Nichols AV; Blanche PJ; Genzel-Boroviczeny O; Forte TM; Gong EL
    Biochim Biophys Acta; 1991 Oct; 1085(3):306-4. PubMed ID: 1911864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.